Cargando…
GRAZAX®: a sublingual immunotherapy vaccine for Hay fever treatment: from concept to commercialization
Allergen immunotherapy has been used for more than 100 y, but only recently underlying immunological mechanisms have started to be understood. New Allergy vaccines are now considered to be full pharmaceutical products, that should comply with general as well as specific pharmaceutical legal framewor...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Taylor & Francis
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930101/ https://www.ncbi.nlm.nih.gov/pubmed/31157592 http://dx.doi.org/10.1080/21645515.2019.1622976 |